Invention Grant
- Patent Title: Pharmaceutical compositions of a selective c-kit kinase inhibitor and methods for making and using same
-
Application No.: US17455739Application Date: 2021-11-19
-
Publication No.: US11744823B2Publication Date: 2023-09-05
- Inventor: Gregg F. Keaney , Elizabeth Kwong
- Applicant: Third Harmonic Bio, Inc.
- Applicant Address: US MA Cambridge
- Assignee: Third Harmonic Bio, Inc.
- Current Assignee: Third Harmonic Bio, Inc.
- Current Assignee Address: US MA Cambridge
- Agency: Dechert LLP
- Agent Andrea L. C. Reid; Chad E. Davis
- Main IPC: A61K31/437
- IPC: A61K31/437 ; A61K9/16
Abstract:
The present disclosure relates generally to pharmaceutical compositions of N-(5-(5-((1R,2S)-2-fluorocyclopropyl)-1,2,4-oxadiazol-3-yl)-2-methylphenyl)imidazo[1,2-a]pyridine-3-carboxamide useful as a selective inhibitor of c-kit kinase and uses of the same in the treatment of c-kit kinase associated diseases.
Public/Granted literature
- US20220184045A1 PHARMACEUTICAL COMPOSITIONS OF A SELECTIVE C-KIT KINASE INHIBITOR AND METHODS FOR MAKING AND USING SAME Public/Granted day:2022-06-16
Information query
IPC分类:
